Signs of Alzheimer’s disease could be detectable in the blood as early as middle age, a study has found, raising hopes that ...

A Finnish population study shows that signs related to Alzheimer’s disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's disease ...

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

Blood tests could reveal early signs of Alzheimer’s disease, study finds - Researchers say the findings provide new insights ...

Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...

A Finnish population study shows that signs related to Alzheimer’s disease may already be found in the brain in middle age.

Preclinical candidate data expected in early 2026, with exclusive option for Acumen to develop up to two development candidates for the treatment of Alzheimer’s disease Agreement follows more than one ...